Moderna COVID-19 Vaccines | Info for Teens https://eua.modernatx.

com/recipients/teens

This page is intended for US residents only. For Vaccination Providers

Authorized Use EUA Fact Sheets EUA Le�ers Report Adverse Event Tools

Our Vaccines Adults Teens Children Safety Resources FAQ

Minimize -

IMPORTANT SAFETY INFORMATION Close

Moderna is helping protect teens from

AUTHORIZED USE

COVID-19
Emergency uses of the vaccine have not been approved or licensed by the FDA, but
have been authorized by the FDA, under an Emergency Use Authorization (EUA) to
prevent Coronavirus Disease 2019 (COVID-19). The Moderna COVID-19 Vaccine is
authorized in individuals 6 months of age and older as a primary series. The Moderna
COVID-19 Vaccine, Bivalent is authorized as a booster dose in individuals 6 months
through 5 years of age at least 2 months a�er the Moderna COVID-19 Vaccine primary
series and is authorized in individuals 6 years of age and older at least 2 months a�er
any authorized or approved vaccine.

The EUA for these products is in e�ect for the duration of the COVID-19 EUA declaration
justifying emergency use of the product, unless the declaration is terminated or the
authorization is revoked sooner.

For more information on the EUA authorized uses of the vaccine, refer to the Vaccine
Fact Sheets for Recipients and Caregivers.

What should you mention to the vaccination provider before you or your child gets
these vaccines?
Tell your vaccination provider about all medical conditions, including if you or your child:

Teens are eligible for the Moderna COVID-19

have any allergies

have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of

theVaccine,
lining outside theBivalent,
heart) authorized for use in
have a fever
people 12 through 17 years of age.
have a bleeding disorder or are on a blood thinner

are immunocompromised or are on a medicine that a�ects your or your child’s immune
With the Moderna COVID-19 Vaccine, Bivalent, you and your child's doctor have another
system

1 of 7 4/10/23, 10:15
Moderna COVID-19 Vaccines | Info for Teens https://eua.modernatx.com/recipients/teens

tool to
help
protect
your child
from
COVID-19.

Minimize -

IMPORTANT SAFETY INFORMATION Close

AUTHORIZED USE
Eligibility and dosing for teens
Emergency uses of the vaccine have not been approved or licensed by the FDA, but
Moderna COVID-19
have been Vaccine,
authorized by Bivalent
the FDA,should
under be
an given at least
Emergency 2 months
Use a�er people
Authorization 12
(EUA) to
through 17 years
prevent of age have
Coronavirus received:
Disease 2019 (COVID-19). The Moderna COVID-19 Vaccine is
authorized in individuals 6 months of age and older as a primary series. The Moderna
A booster Vaccine,
COVID-19 dose of the original
Bivalent Moderna COVID-19
is authorized Vaccine
as a booster doseorinanother authorized
individuals 6 months
monovalent COVID-19
through 5 years of agevaccine
at least 2 months a�er the Moderna COVID-19 Vaccine primary
series and(original)
A primary is authorized
seriesinof
individuals 6 years
the Moderna of age Vaccine
COVID-19 and olderoratanother
least 2 authorized
months a�er
any authorized
monovalent or approved
COVID-19 vaccinevaccine.

The EUA for these products is in e�ect for the duration of the COVID-19 EUA declaration
The justifying
Modernaemergency
COVID-19 Vaccine is authorized
use of the for usethe
product, unless asdeclaration
the initial 2-dose primaryor
is terminated series
the in
people 12 years ofisage
authorization and older.
revoked sooner.

For more information on the EUA authorized uses of the vaccine, refer to the Vaccine
The vaccine is administered as a 2-dose primary series, 1 month apart
Fact Sheets for Recipients and Caregivers.
A third primary series dose may be administered at least 1 month a�er the second dose
to should
What people you
withmention
certain kinds ofvaccination
to the immunocompromise
provider before you or your child gets
these vaccines?
Tell your vaccination provider about all medical conditions, including if you or your child:

have any allergies

have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of

the lining outside the heart)

have a fever
Primary series
have a bleeding vaccine:
disorder or are onHelps protect against COVID-19
a blood thinner

are immunocompromised or are on a medicine that a�ects your or your child’s immune
A U.S. clinical study conducted by Moderna, known as the TeenCOVE trial, measured the
system

2 of 7 4/10/23, 10:15
Moderna COVID-19 Vaccines | Info for Teens https://eua.modernatx.com/recipients/teens

safety and e�cacy of the Moderna COVID-19 Vaccine in healthy adolescents 12 through 17
years of age.

Based on the study, the vaccine showed to be:

Minimize -

IMPORTANT SAFETY INFORMATION Close

93% e�ective against

AUTHORIZED USE
COVID-19 infection

Emergency
Based onuses of the vaccine
the Centers have Control
for Disease not been approved
and or licensed
Prevention by the
(CDC) case FDA, but
definition*
have been authorized by the FDA, under an Emergency Use Authorization (EUA) to
prevent Coronavirus Disease 2019 (COVID-19). The Moderna COVID-19 Vaccine is
authorized in individuals 6 months of age and older as a primary series. The Moderna
COVID-19 Vaccine, Bivalent is authorized as a booster dose in individuals 6 months
through 5 years of age at least 2 months a�er the Moderna COVID-19 Vaccine primary
series and is authorized in individuals 6 years of age and older at least 2 months a�er
any authorized or approved vaccine.

The EUA for these products is in e�ect for the duration of the COVID-19 EUA declaration
justifying emergency use of the100% e�ective
product, unlessagainst
the declaration is terminated or the
authorization is revoked sooner. COVID-19 infection

For more information on Based

the EUA †
onauthorized
the COVEuses
caseof the vaccine,
definition refer to the Vaccine
Fact Sheets for Recipients and Caregivers.

What should you mention to the vaccination provider before you or your child gets
* these
CDC case vaccines?
definition: 1 systemic symptom and a positive reverse transcription polymerase chain reaction (RT-PCR).

†
Tell your vaccination provider about all medical conditions, including if you or your child:
COVE case definition: 2 systemic or 1 respiratory symptom and a positive RT-PCR.

have any allergies

have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of

the lining outside the heart)

have a fever

have a bleeding disorder or are on a blood thinner

are immunocompromised or are on a medicine that a�ects your or your child’s immune
system

3 of 7 4/10/23, 10:15
Moderna COVID-19 Vaccines | Info for Teens https://eua.modernatx.com/recipients/teens

What should I tell my healthcare provider before

vaccination?
Before you or your child receive an age-appropriate Moderna COVID-19 Vaccine, tell your
healthcare provider about all your/your child's medical conditions, including if you or your
Minimize -
child:

IMPORTANT SAFETY INFORMATION

have any allergies Close

have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of

AUTHORIZED USE
the lining outside the heart)

have a feveruses of the vaccine have not been approved or licensed by the FDA, but
Emergency
have a been authorized
bleeding by the
disorder FDA,
or are on under anthinner
a blood Emergency Use Authorization (EUA) to
prevent Coronavirus Disease 2019 (COVID-19). The Moderna COVID-19 Vaccine is
are immunocompromised or are on a medicine that a�ects your immune system
authorized in individuals 6 months of age and older as a primary series. The Moderna
are pregnant
COVID-19 or plan
Vaccine, to become
Bivalent pregnantas a booster dose in individuals 6 months
is authorized
through
are 5 years of age at least 2 months a�er the Moderna COVID-19 Vaccine primary
breastfeeding
series and is authorized in individuals 6 years of age and older at least 2 months a�er
have received another COVID-19 vaccine
any authorized or approved vaccine.
have ever fainted in association with an injection
The EUA for these products is in e�ect for the duration of the COVID-19 EUA declaration
justifying emergency use of the product, unless the declaration is terminated or the
authorization
Download What tois revoked sooner.
Expect Guide
For more information on the EUA authorized uses of the vaccine, refer to the Vaccine
Fact Sheets for Recipients and Caregivers.

What should you mention to the vaccination provider before you or your child gets
these vaccines?
Tell your vaccination provider about all medical conditions, including if you or your child:

have any allergies

Learn about
have had potential
myocarditis vaccination
(inflammation side or
of the heart muscle) e�ects
pericarditis (inflammation of
the lining outside the heart)
Serious reactions include:
have a fever

have a bleeding
Severe disorder or are on a blood thinner
allergic reactions
are immunocompromised or are on a medicine that a�ects your or your child’s immune
Urticaria
system

4 of 7 4/10/23, 10:15
Moderna COVID-19 Vaccines | Info for Teens https://eua.modernatx.com/recipients/teens

Myocarditis (inflammation of the heart muscle)

Pericarditis (inflammation of the lining outside the heart)

Fainting in association with injection of the vaccines

If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital.

For individuals 6 years of age and older, general side e�ects can include: Minimize -

Fatigue
IMPORTANT SAFETY INFORMATION Close
Headache
AUTHORIZED USE
Muscle pain

Joint pain uses of the vaccine have not been approved or licensed by the FDA, but
Emergency
Chillsbeen authorized by the FDA, under an Emergency Use Authorization (EUA) to
have
prevent
Nausea Coronavirus
and vomitingDisease 2019 (COVID-19). The Moderna COVID-19 Vaccine is
authorized in individuals 6 months of age and older as a primary series. The Moderna
Fever
COVID-19 Vaccine, Bivalent is authorized as a booster dose in individuals 6 months
Rash
through 5 years of age at least 2 months a�er the Moderna COVID-19 Vaccine primary
series and is authorized in individuals 6 years of age and older at least 2 months a�er
Sideany
e�ects
authorized
a�er ge�ing
or approved
a COVID-19
vaccine.vaccine can vary from person to person. Talk to your
healthcare provider if you have any
is inside e�ects that bother of
you orCOVID-19
do not goEUA
away.
The EUA for these products e�ect for the duration the declaration
justifying emergency use of the product, unless the declaration is terminated or the
See Safety Info
authorization is revoked sooner.

For more information on the EUA authorized uses of the vaccine, refer to the Vaccine
Fact Sheets for Recipients and Caregivers.

What should you mention to the vaccination provider before you or your child gets
these vaccines?
Tell your vaccination provider about all medical conditions, including if you or your child:

have any allergies

Frequently Asked
have had myocarditis Questions
(inflammation of the heart muscle) or pericarditis (inflammation of
the lining outside the heart)
We have answers in the FAQ section.
have a fever

have a bleeding disorder or are on a blood thinner

are immunocompromised or are on a medicine that a�ects your or your child’s immune
system

5 of 7 4/10/23, 10:15
Moderna COVID-19 Vaccines | Info for Teens https://eua.modernatx.com/recipients/teens

Minimize -

IMPORTANT SAFETY INFORMATION Close

AUTHORIZED USE

Stay connected with Moderna

Emergency uses of the vaccine have not been approved or licensed by the FDA, but
Sign
have up toauthorized
been receivebyupdates from
the FDA, under Moderna
an Emergency Use Authorization (EUA) to
prevent Coronavirus Disease 2019 (COVID-19). The Moderna COVID-19 Vaccine is
authorized in individuals 6 months of age and older as a primary series. The Moderna
COVID-19
First Name Vaccine, Bivalent is authorized as a booster dose in individuals 6 months
through 5 years of age at least 2 months a�er the Moderna COVID-19 Vaccine primary
series and is authorized in individuals 6 years of age and older at least 2 months a�er
any authorized or approved vaccine.
Last Name
The EUA for these products is in e�ect for the duration of the COVID-19 EUA declaration
justifying emergency use of the product, unless the declaration is terminated or the
authorization is revoked sooner.
Email Address
For more information on the EUA authorized uses of the vaccine, refer to the Vaccine
Fact Sheets for Recipients and Caregivers.

Phone
What Number
should you mention to the vaccination provider before you or your child gets
these vaccines?
Tell your vaccination provider about all medical conditions, including if you or your child:

haveI'dany
likeallergies
to receive Moderna communications via email. I understand that I can opt out
haveathad
anymyocarditis
time (inflammation of the heart muscle) or pericarditis (inflammation of
the lining outside the heart)
By submi�ing your information, you agree to Moderna’s Terms and Conditions. You also
have a fever
acknowledge that your information will be processed in accordance with Moderna’s Privacy
have a bleeding disorder or are on a blood thinner
Policy.
are immunocompromised or are on a medicine that a�ects your or your child’s immune
system

6 of 7 4/10/23, 10:15
Moderna COVID-19 Vaccines | Info for Teens https://eua.modernatx.com/recipients/teens

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Services
apply.

Subscribe

Minimize -

About Moderna
IMPORTANT SAFETY INFORMATION Close
ModernaTX.com
AUTHORIZED USE
1-866-MODERNA (1-866-663-3762)
Emergency
8:00AM uses
- 8:00PM ofMonday-Friday
EST, the vaccine have not been approved or licensed by the FDA, but
(nothave beenHolidays)
including authorized by the FDA, under an Emergency Use Authorization (EUA) to
prevent Coronavirus Disease 2019 (COVID-19). The Moderna COVID-19 Vaccine is
MedInfo@modernatx.com
authorized in individuals 6 months of age and older as a primary series. The Moderna
COVID-19 Vaccine, Bivalent is authorized as a booster dose in individuals 6 months
through 5 years of age at least 2 months a�er the Moderna COVID-19 Vaccine primary
series and is authorized in individuals 6 years of age and older at least 2 months a�er
any authorized or approved vaccine.

The EUA for these products is in e�ect for the duration of the COVID-19 EUA declaration
justifying emergency use of the product, unless the declaration is terminated or the
© 2023 Moderna US-COV-2200381 03/2023
authorization is revoked sooner.
Privacy Policy Terms of Use

For more information on the EUA authorized uses of the vaccine, refer to the Vaccine
Fact Sheets for Recipients and Caregivers.

What should you mention to the vaccination provider before you or your child gets
these vaccines?
Tell your vaccination provider about all medical conditions, including if you or your child:

have any allergies

have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of

the lining outside the heart)

have a fever

have a bleeding disorder or are on a blood thinner

are immunocompromised or are on a medicine that a�ects your or your child’s immune
system

7 of 7 4/10/23, 10:15